The market for aerosol delivery devices is expected to grow at a CAGR of around 4.3% from 2020 to 2027 and expected to reach the market value of around US$ 47,685.4 Mn by 2027.
An aerosol is a suspension of liquid or solid particles in a carrier gas. Aerosol delivery devices have evolved from the basic pressurized metered-dose inhaler and nebulizer to numerous types of inhalers and devices, including dry powder inhalers, soft mist inhalers, valve holder chambers, and smart inhalers & nebulizers. These devices deliver aerosolized drugs directly into the lungs and have the advantage of higher drug concentration delivered more effectively to the airways along with the reduced systemic adverse effects. Additionally, aerosol drug delivery is painless and convenient and can improve a patient's ability to self-administer medication. Moreover, some drugs are therapeutically active only when inhaled.
Market Dynamics
The increasing usage of aerosol delivery devices like dry powder inhalers, metered-dose inhalers, and nebulizers for the treatment of asthma and COPD is driving the market growth. These devices are also used in non-respiratory diseases such as diabetes, analgesia, and Parkinson’s disease which is also supporting growth. The rising prevalence of respiratory diseases such as COPD, asthma, and cystic fibrosis, surging focus of manufacturers toward the development of portable inhalation devices, rising demand for short-term, effective medication for asthma, and COPD are further bolstering the market value. The increasing geriatric population, technological advancements in inhaler devices, rising adoption of aerosol delivery devices by patients, rapid urbanization coupled with the increasing pollution levels are boosting the demand for aerosol delivery devices. Additionally, government initiatives to spread awareness about COPD and asthma symptoms in developing and underdeveloped economies as well as ongoing R&D activities to develop ideal inhalation therapy are further projected to provide potential opportunities over the estimated period.
On the other side, the complications and side-effects associated with drug inhalation and high cost associated with nebulizers are projected to restrict the market growth over the forecast period from 2020 to 2027.
North America accounted for the maximum revenue share in the global Aerosol Delivery Devices market
In 2019, North America registered a major share in terms of revenue in the aerosol delivery devices market. The presence of major players in the region along with the increasing number of patients with chronic respiratory diseases is supporting the regional market value. Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death in America. According to studies, in 2009 around 40.3 million Americans were diagnosed with asthma or COPD. Furthermore, the Asia Pacific region is anticipated to experience the fastest growth with major CAGR during the forecast timeframe from 2020 to 2027.
The players profiled in the report include 3M Company, Aerogen, Inc., Gerresheimer AG, GlaxoSmithKline Plc (GSK), Heitkamp & Thumann KG (H&T Presspart), Iconovo AB, Johnson & Johnson (Actelion Pharmaceuticals Ltd), Koninklijke Philips N.V., Merck & Co., Inc., Merxin Ltd, Metall Zug Group (Clement Clarke International Ltd), Nemera, Recipharm AB (Bespak), Teva Pharmaceutical Industries Limited, and Vectura Group PLC. The major aerosol delivery devices players were involved in strategic developments for escalating the profit share in regional as well as the global market. The major investments were announced in the aerosol delivery devices market for technological advancements in the field.
Market Segmentation
Market By Product
Dry powder inhalers
- Single dose inhalers
- Multi dose inhalers
Metered dose inhalers
- Conventional pressurized inhalers,
- Soft mist inhalers
Nebulizers
- Jet nebulizers
- Ultrasonic wave nebulizers
- Vibrating mesh nebulizers
Market By Application
Asthma
Chronic obstructive pulmonary disease
Cystic fibrosis
Non respiratory diseases
Diabetes
Analgesia
Parkinson’s disease
Market By Distribution Channel
Retail pharmacies
Hospital pharmacies
E-commerce
Market By Geography
North America
Europe
- U.K.
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
Chapter 1. Industry Overview of Aerosol Delivery Devices
1.1 Definition and Scope
1.1.1 Definition of Aerosol Delivery Devices
1.1.2 Market Segmentation
1.1.3 Years Considered for the Study
1.1.4 Assumptions and Acronyms Used
1.1.4.1 Market Assumptions and Market Forecast
1.1.4.2 Acronyms Used In Global Aerosol Delivery Devices Market
1.2 Summary
1.2.1 Executive Summery
1.2.2 Aerosol Delivery Devices Market By Product
1.2.3 Global Aerosol Delivery Devices Market By Application
1.2.4 Global Aerosol Delivery Devices Market By Distribution Channel
1.2.5 Global Aerosol Delivery Devices Market by Regions
Chapter 2. Research Approach
2.1 Methodology
2.1.1 Research Programs/By Distribution Channel
2.1.2 Market Size Estimation
2.1.3 Market Breakdown and Data Triangulation
2.2 Data Source
2.2.1 Secondary Sources
2.2.2 Primary Sources
Chapter 3. Market Dynamics and Competition Analysis
3.1 Market Drivers
3.1.1 Driver 1
3.1.2 Driver 2
3.2 Restraints and Challenges
3.2.1 Restraint 1
3.2.2 Restraint 2
3.3 Growth Opportunities
3.3.1 Opportunity 1
3.3.2 Opportunity 2
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Threat of Substitute
3.4.4 Threat of New Entrants
3.4.5 Degree of Competition
3.5 Market Concentration Ratio And Market Maturity Analysis of Aerosol Delivery Devices Market
3.5.1 Go To Market Strategy
3.5.1.1 Introduction
3.5.1.2 Growth
3.5.1.3 Maturity
3.5.1.4 Saturation
3.5.1.5 Possible Development
3.6 Technological Roadmap for Aerosol Delivery Devices Market
3.7 Value Chain Analysis
3.7.1 List of Key Manufacturers
3.7.2 List of Customers
3.7.3 Level of Integration
3.8 Cost Structure Analysis
3.8.1 Price Trend of Key Raw Materials
3.8.2 Raw Material and Suppliers
3.8.3 Proportion of Manufacturing Cost Structure
3.8.3.1 Raw Material
3.8.3.2 Labor Cost
3.8.3.3 Manufacturing Expense
3.9 Regulatory Compliance
3.10 Competitive Landscape, 2019
3.10.1 Player Positioning Analysis
3.10.2 Key Strategies Adopted By Leading Players
Chapter 4. Manufacturing Plant Analysis
4.1 Manufacturing Plant Location and Establish Date of Global Aerosol Delivery Devices Major Manufacturers in 2019
4.2 R&D Status and By Application Source of Global Aerosol Delivery Devices Major Manufacturers in 2019
Chapter 5. Aerosol Delivery Devices Market By Product
5.1 Introduction
5.2 Global Aerosol Delivery Devices Revenue (US$ Mn) by Product
5.2.1 Global Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Product, 2016 – 2027
5.2.2 Dry powder inhalers
5.2.2.1 Dry powder inhalers Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
5.2.2.1.1 Single dose inhalers
5.2.2.1.1.1 Single dose inhalers Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
5.2.2.1.2 Multi dose inhalers
5.2.2.1.2.1 Multi dose inhalers Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
5.2.3 Metered dose inhalers
5.2.3.1 Metered dose inhalers Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
5.2.3.1.1 Conventional pressurized inhalers
5.2.3.1.1.1 Conventional pressurized inhalers Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
5.2.3.1.2 Soft mist inhalers
5.2.3.1.2.1 Soft mist inhalers Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
5.2.4 Nebulizers
5.2.4.1 Nebulizers Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
5.2.4.1.1 Jet nebulizers
5.2.4.1.1.1 Jet nebulizers Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
5.2.4.1.2 Ultrasonic wave nebulizers
5.2.4.1.2.1 Ultrasonic wave nebulizers Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
5.2.4.1.3 Vibrating mesh nebulizers
5.2.4.1.3.1 Vibrating mesh nebulizers Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
5.3 Market Attractive Analysis By Product 2019
Chapter 6. Aerosol Delivery Devices Market By Application
6.1 Introduction
6.2 Global Aerosol Delivery Devices Revenue (US$ Mn) by Application
6.2.1 Global Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
6.2.2 Asthma
6.2.2.1 Asthma Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
6.2.3 Chronic obstructive pulmonary disease
6.2.3.1 Chronic obstructive pulmonary disease Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
6.2.4 Cystic fibrosis
6.2.4.1 Cystic fibrosis Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
6.2.5 Non respiratory diseases
6.2.5.1 Non respiratory diseases Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
6.2.5.1.1 Diabetes
6.2.5.1.1.1 Diabetes Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
6.2.5.1.2 Analgesia
6.2.5.1.2.1 Analgesia Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
6.2.5.1.3 Parkinson’s disease
6.2.5.1.3.1 Parkinson’s disease Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
6.3 Market Attractive Analysis By Application 2019
Chapter 7. Aerosol Delivery Devices Market By Distribution Channel
7.1 Introduction
7.2 Global Aerosol Delivery Devices Revenue (US$ Mn) by Distribution Channel
7.2.1 Global Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
7.2.2 Retail pharmacies
7.2.2.1 Retail pharmacies Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
7.2.3 Hospital pharmacies
7.2.3.1 Hospital pharmacies Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
7.2.4 E-commerce
7.2.4.1 E-commerce Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
7.3 Market Attractive Analysis By Distribution Channel 2019
Chapter 8. North America Aerosol Delivery Devices Market By Country
8.1 North America Aerosol Delivery Devices Market Overview
8.2 U.S.
8.2.1 U.S. Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
8.2.2 U.S. Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
8.2.3 U.S. Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
8.3 Canada
8.3.1 Canada Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
8.3.2 Canada Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
8.3.3 Canada Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
8.4 North America PEST Analysis
Chapter 9. Europe Aerosol Delivery Devices Market By Country
9.1 Europe Aerosol Delivery Devices Market Key Overview
9.2 UK
9.2.1 UK Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
9.2.2 UK Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
9.2.3 UK Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
9.3 Germany
9.3.1 Germany Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
9.3.2 Germany Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
9.3.3 Germany Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
9.4 France
9.4.1 France Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
9.4.2 France Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
9.4.3 France Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
9.5 Spain
9.5.1 Spain Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
9.5.2 Spain Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
9.5.3 Spain Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
9.6 Rest of Europe
9.6.1 Rest of Europe Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
9.6.2 Rest of Europe Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
9.6.3 Rest of Europe Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
9.7 Europe PEST Analysis
Chapter 10. Asia-Pacific Aerosol Delivery Devices Market By Country
10.1 Asia Pacific Aerosol Delivery Devices Market Overview
10.2 China
10.2.1 China Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
10.2.2 China Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.2.3 China Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
10.3 Japan
10.3.1 Japan Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
10.3.2 Japan Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.3.3 Japan Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
10.4 India
10.4.1 India Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
10.4.2 India Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.4.3 India Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
10.5 Australia
10.5.1 Australia Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
10.5.2 Australia Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.5.3 Australia Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
10.6 South Korea
10.6.1 South Korea Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
10.6.2 South Korea Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.6.3 South Korea Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
10.7 Rest of Asia-Pacific
10.7.1 Rest of Asia Pacific Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
10.7.2 Rest of Asia Pacific Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.7.3 Rest of Asia Pacific Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
10.8 Asia Pacific PEST Analysis
Chapter 11. Latin America Aerosol Delivery Devices Market By Country
11.1 Latin America Aerosol Delivery Devices Market Overview
11.2 Brazil
11.2.1 Brazil Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
11.2.2 Brazil Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
11.2.3 Brazil Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
11.3 Mexico
11.3.1 Mexico Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
11.3.2 Mexico Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
11.3.3 Mexico Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
11.4 Rest of Latin America
11.4.1 Rest of Latin America Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
11.4.2 Rest of Latin America Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
11.4.3 Rest of Latin America Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
11.5 Latin America PEST Analysis
Chapter 12. Middle East & Africa Aerosol Delivery Devices Market By Country
12.1 Middle East & Africa Aerosol Delivery Devices Market Overview
12.2 Saudi Arabia
12.2.1 Saudi Arabia Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
12.2.2 Saudi Arabia Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
12.2.3 Saudi Arabia Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
12.3 UAE
12.3.1 UAE Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
12.3.2 UAE Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
12.3.3 UAE Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
12.4 Rest of Middle East & Africa
12.4.1 Rest of Middle East & Africa Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
12.4.2 Rest of Middle East & Africa Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
12.4.3 Rest of Middle East & Africa Aerosol Delivery Devices Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
12.5 South Africa PEST Analysis
Chapter 13. Player Analysis of Aerosol Delivery Devices
13.1 Global Aerosol Delivery Devices Market Company Share Analysis
13.2 Competition Matrix
13.2.1 Competitive Benchmarking of key players by price, presence, market share, and R&D investment
13.2.2 New Product Launches and Product Enhancements
13.2.3 Mergers And Acquisition In Global Aerosol Delivery Devices Market
13.2.4 Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
Chapter 14. Company Profile
14.1 3M Company
14.1.1 Company Snapshot
14.1.2 Business Overview
14.1.3 Financial Overview
14.1.3.1 Revenue (US$ Mn), 2019
14.1.3.2 3M Company 2019 Aerosol Delivery Devices Business Regional Distribution
14.1.4 Product/Service and Specifications
14.1.5 Recent Development & Business Strategy
14.1.6 Manufacturing Plant Footprint Analysis
14.2 Aerogen, Inc.
14.3 Gerresheimer AG
14.4 Glaxosmithkline Plc (GSK)
14.5 Heitkamp & Thumann KG (H&T Presspart)
14.6 Iconovo AB
14.7 Johnson & Johnson (Actelion Pharmaceuticals Ltd)
14.8 Koninklijke Philips N.V.
14.9 Merck & Co., Inc.
14.10 Merxin Ltd
14.11 Metall Zug Group (Clement Clarke International Ltd)
14.12 Nemera
14.13 Recipharm AB (Bespak)
14.14 Teva Pharmaceutical Industries Limited
14.15 Vectura Group PLC
14.16 Others
